drugset / Trial / NCT06421714
A Study of the Safety, Tolerability, and Pharmacokinetics of Orally Administered Venglustat and Itraconazole in Healthy Adult Male Participants
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to assess in healthy adult male participants the effects of itraconazole on the pharmacokinetics of venglustat and to assess the safety and tolerability of venglustat with and without coadministration of itraconazole. The maximum duration for participants from screening is between 32 to 62 days.
Timeline
- Start
- 2018-08-16
- Primary completion
- 2018-10-14
- Completion
- 2018-10-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Itraconazole | Small molecule | — | Oral |
| Subject | Venglustat | Small molecule | — | Oral |
Indications
No indication recorded.